According to a statement sent out Monday night by Texas Health Presbyterian Hospital. it said that the patient was being isolated based on his or her symptoms and recent travel history.
It was gathered from the spokeswoman for the Texas Department of State Health Services, Carrie Williams, that specimens from the patient were tested by a state lab and confirmed Tuesday by a separate test by the Centers for Disease Control.
Confirming the situation during a press conference held in Dallas Tuesday afternoon, Tom Frieden, M.D., Director of the Center for Disease Control, said that the unnamed patient did not show any symptoms when leaving Liberia on 19 September or entering the U.S. on 20 September.
It was revealed that the patient sought treatment on 26 September and was admitted to a hospital on 28 September.
During his first visit to the hospital, he complained of illness but was released before returning Sept. 28 as his condition worsened. A hospital official said it wasn’t until then that they discovered he was in West Africa.
Dr. Edward Goodman with Texas Health Presbyterian Hospital informed that there isn’t any more ZMapp available, which is an experimental drug that was used on two previous Ebola patients.
However, Frieden said the hospital is discussing if experimental treatments would be appropriate.
No comments:
Post a Comment